Upgrade to SI Premium - Free Trial

SELLAS Life Sciences (SLS)

8.23 -0.81 (8.96%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Form 8-K SELLAS Life Sciences For: Jun 02 June 2, 2026 8:30 AM - SEC Filing SELLAS Life Sciences to Participate in Upcoming Investor Conferences May 14, 2026 8:01 AM - Globe NewsWire SELLAS Life Sciences Group, Inc. (SLS) Tops Q1 EPS by 2c May 12, 2026 4:41 PM - StreetInsider Form 8-K SELLAS Life Sciences For: May 12 May 12, 2026 4:08 PM - SEC Filing SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update May 12, 2026 4:05 PM - Globe NewsWire Form 10-Q SELLAS Life Sciences For: Mar 31 May 12, 2026 4:02 PM - SEC Filing Form SCHEDULE 13G/A SELLAS Life Sciences Filed by: BlackRock, Inc. April 24, 2026 4:13 PM - SEC Filing Form ARS SELLAS Life Sciences For: Dec 31 April 23, 2026 7:01 PM - SEC Filing Form DEFA14A SELLAS Life Sciences April 23, 2026 7:01 PM - SEC Filing Form DEF 14A SELLAS Life Sciences For: Jun 16 April 23, 2026 7:01 PM - SEC Filing The Supply Gap No One's Talking About Is Repricing Copper Developers April 16, 2026 11:30 AM - Globe NewsWire Form SCHEDULE 13G/A SELLAS Life Sciences Filed by: VANGUARD GROUP INC March 27, 2026 1:01 PM - SEC Filing Form S-3ASR SELLAS Life Sciences March 20, 2026 5:01 PM - SEC Filing Form 8-K SELLAS Life Sciences For: Mar 19 March 19, 2026 4:09 PM - SEC Filing SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update March 19, 2026 4:05 PM - Globe NewsWire Form 10-K SELLAS Life Sciences For: Dec 31 March 19, 2026 4:01 PM - SEC Filing SELLAS to present preclinical data on SLS009 at AACR conference March 17, 2026 4:30 PM - StreetInsider SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference March 17, 2026 4:30 PM - Globe NewsWire SELLAS Life Sciences enrolls first patient in phase 2 AML trial March 12, 2026 8:44 AM - StreetInsider SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009 March 12, 2026 8:35 AM - Globe NewsWire Form 8-K SELLAS Life Sciences For: Mar 11 March 11, 2026 4:06 PM - SEC Filing Full Article List